1 施鸿生,王苏民,刘宇红,等.结核病耐药检测述略[J].中华结核和呼吸杂志,2000,23:391~292.
2 屠德华.耐药性结核病的流行病学特征和意义[J].中华结核和呼吸杂志,1997,20:227~227.
3 中国防痨协会.结核病诊断细菌学检验规程[J].中国防痨杂志,1996,18:28.
4 中华医学会结核病科学会.肺结核化学疗法[J].中华结核和呼吸系疾病杂志,1982,6:381~285.
5 Fox W. The current status of short course chemotherapy [J] . Bull int Union Tuberc,1978,53:268~270.
6 陆宇,朱莉贞,段连山.氟喹诺酮类药物的抗结核作用[J].中华结合和呼吸杂志,1999,22:693~295.
7 Rastog N, Goh KS, Bryskier A, et al. In vitro activities of levo-floxacin used alone and in combination with first and second-line antituberculosis drugs against mycobacterium tuberculosis[J] . An-timicrob Agents Chemother, 1996,40:1610~1616.
8 何国钧,肖和平.抗结核药物的研究进展[J].中华结核和呼吸杂志,2000,23:621.
9 刘又宁.浅议应用氟喹诺酮类抗菌药物治疗呼吸系感染的利弊[J].中华结合和呼吸杂志,1998,21(1):69.
10 Klemens SP, Sharpe CA , Rogge M C,et al. Activity of levofloxacin in a murine model of tuberculosis[J] . Antimicrob Agents Chemother. 1994;38:1476~2479.
11 Ji B,Lounis N,Truffot-pernot C, et al. In Vitro and in vivo activities of levofloxacin against Mycobacterium tuberculosis[J] . Antimicrob Agents Chemother, 1995,39:1341~1344.
12 American Thoracic Society. Theatment of tuberculosis and tuberculosis infection in adults and children [J]. Am J Respir Crit Care Med.,1994,149:1359.